GoalVest Advisory’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.77M | Buy |
14,945
+277
| +2% | +$51.4K | 0.69% | 23 |
|
|
2025
Q1 | $3.07M | Buy |
14,668
+1,262
| +9% | +$264K | 0.84% | 19 |
|
|
2024
Q4 | $2.38M | Sell |
13,406
-166
| -1% | -$29.5K | 0.65% | 27 |
|
|
2024
Q3 | $2.68M | Sell |
13,572
-288
| -2% | -$56.9K | 0.77% | 18 |
|
|
2024
Q2 | $2.38M | Sell |
13,860
-997
| -7% | -$171K | 0.76% | 16 |
|
|
2024
Q1 | $2.71M | Buy |
14,857
+8,160
| +122% | +$1.49M | 0.9% | 12 |
|
|
2023
Q4 | $1.04M | Buy |
6,697
+5,858
| +698% | +$908K | 0.46% | 36 |
|
|
2023
Q3 | $125K | Buy |
839
+7
| +0.8% | +$1.04K | 0.06% | 90 |
|
|
2023
Q2 | $112K | Sell |
832
-50
| -6% | -$6.74K | 0.06% | 93 |
|
|
2023
Q1 | $141K | Buy |
882
+90
| +11% | +$14.3K | 0.08% | 78 |
|
|
2022
Q4 | $128K | Buy |
792
+50
| +7% | +$8.08K | 0.08% | 83 |
|
|
2022
Q3 | $100K | Sell |
742
-317
| -30% | -$42.7K | 0.07% | 92 |
|
|
2022
Q2 | $163K | Buy |
1,059
+854
| +417% | +$131K | 0.1% | 117 |
|
|
2022
Q1 | $33K | Buy |
+205
| New | +$33K | 0.02% | 173 |
|
|
2021
Q2 | $279K | Sell |
2,477
-3,285
| -57% | -$370K | 0.17% | 112 |
|
|
2021
Q1 | $624K | Buy |
5,762
+131
| +2% | +$14.2K | 0.47% | 73 |
|
|
2020
Q4 | $603K | Buy |
+5,631
| New | +$603K | 0.51% | 62 |
|